Trademark: 79205165
Word
DRAINHUNT
Status
Registered
Status Code
700
Status Date
Tuesday, January 30, 2018
Serial Number
79205165
Registration Number
5388879
Registration Date
Tuesday, January 30, 2018
Mark Type
4000
Filing Date
Friday, September 30, 2016
Published for Opposition
Tuesday, November 14, 2017

Trademark Owner History
Immungenetics AG - Original Registrant

Classifications
5 Biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in trinucleotide repeat disorders, in particular for use in Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing trinucleotide repeat disorders, in particular for preventing Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of trinucleotide repeat disorders, in particular for the treatment of Huntington'a chorea; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's Chorea; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's chorea
1 Chemical products for the production of viral, retroviral and non-viral vectors
DRAIN HUNT

Trademark Events
Jan 30, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 11, 2022
Change Of Name/Address Rec'd From Ib
Mar 11, 2022
New Representative At Ib Received
Nov 12, 2021
New Representative At Ib Received
Jun 8, 2018
Final Decision Transaction Processed By Ib
May 2, 2018
Final Disposition Notice Sent To Ib
May 2, 2018
Final Disposition Processed
Apr 30, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jan 30, 2018
Registered-Principal Register
Nov 14, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2017
Published For Opposition
Oct 25, 2017
Notification Of Notice Of Publication E-Mailed
Oct 9, 2017
Assigned To Lie
Sep 23, 2017
Approved For Pub - Principal Register
Sep 20, 2017
Teas/Email Correspondence Entered
Sep 19, 2017
Correspondence Received In Law Office
Sep 19, 2017
Teas Response To Office Action Received
Sep 19, 2017
Teas Change Of Correspondence Received
May 5, 2017
Refusal Processed By Ib
Apr 19, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Apr 19, 2017
Refusal Processed By Mpu
Apr 19, 2017
Application Filing Receipt Mailed
Apr 16, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Apr 15, 2017
Non-Final Action Written
Apr 15, 2017
Assigned To Examiner
Apr 15, 2017
New Application Office Supplied Data Entered
Apr 13, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24